Safety and efficacy of Clarityne in children <2 years have not yet been established.
Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine; an initial dose of 5 mg or 5 mL once daily, or 10 mg or 10 mL every other day is recommended.